Related Experiment Video
Updated: Feb 16, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Patient outcomes from lung cancer and diabetes mellitus: a matched case-control study
Nina J Karlin1,1, Shailja B Amin1,1, Matthew R Buras2,2
1Division of Hematology & Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ, USA.
Aim:
This case-control study examined the impact of diabetes mellitus (DM) on survival in lung cancer patients and lung cancer on glycemic control in DM.
Materials & Methods:
Patients with a new lung cancer diagnosis and DM (n = 124) were matched to 124 lung cancer patients without DM. Laboratory results and DM and cancer therapies were obtained from electronic records.
Results:
Five-year overall survival for lung cancer patients with and without DM was 20 versus 29% (p = .12). Glycemic control among DM patients did not change significantly with time.
Conclusion:
DM does not cause adverse impact on lung cancer survival. Lung cancer does not affect glycemic control.
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Cancer Survival Analysis